Global Collaborations

Rare diseases affect small and often widely dispersed patient populations. Expertise, data and research opportunities are spread across countries — and no single organisation or region can address these challenges alone. 

Through global collaboration, ERDERA connects people, infrastructures and clinical networks internationally, helping to share knowledge, align priorities, and reduce duplication. This enables better research, faster learning, and clearer pathways from discovery to care — always with patients at the centre. How it works:  

  • Connecting globally 
    We link researchers, clinicians, patients, infrastructures and networks across borders. 
  • Turning priorities into action 
    Shared needs are translated into concrete activities such as calls, services, events and resources. 
  • Sharing outcomes openly 
    Research outputs, tools, events and insights are shared back with the wider community. 

Strategic Alliances

Building long‑term partnerships to align priorities, standards and action.

Supporting IRDiRC

Contributing to global rare disease research coordination through the IRDiRC Scientific Secretariat.

Global CRN networks

Connecting international clinical research communities to strengthen trial readiness and collaboration.

ERN alignment

Working with European Reference Networks to link research and care more effectively.

You might also be interested in

NMGs Sofia

Countries step up joint approaches to rare disease research at first in person ERDERA National Alignment Board meeting

Taking place at a pivotal moment – with the European Rare Disease Plan expected to move forward significantly during 2026 – the meetings brought together National Mirror Group (NMG) representatives from Europe and beyond, alongside European Commission stakeholders, IRDiRC and international partners.
European Parliament

European Parliament draft report urges a binding EU rare disease action framework

A legislative own initiative file in the Parliament’s new public health committee sets out what an EU “rare disease action framework” could look like — and why it could change how Europe measures progress for patients.
Task-Forces-IRDiRC

IRDiRC launches call for experts for four new rare disease activities

Rare disease researchers, clinicians, patient advocates and data experts are invited to help shape four new IRDiRC activities linked to the new IRDiRC Roadmap, with applications closing on 20 February 2026.

How Clinical Research Networks are transforming rare disease research | CRNs conference highlights

ERDERA's

search form